Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases (Q105786933)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases |
clinical trial |
Statements
TUXEDO-1 (English)
0 references
Phase II Study of Trastuzumab-Deruxtecan (T-DX; DS-8201a) in HER2-positive Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases (English)
0 references
28 July 2020
0 references
28 July 2022
0 references
15
0 references
18 year
0 references
100 year
0 references